Hepatitis C virus lymphotropism and peculiar immunological phenotype: Effects on natural history and antiviral therapy
about
Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis.Primary follicular lymphoma of the spleen incidentally found in a patient with alcohol- and hepatitis C-related liver cirrhosis.Successful and Safe Long-Term Standard Antiviral Therapy in a Patient with "Explosive" Immune Response in Course of HCV-Related Liver CirrhosisHepatitis C and non-Hodgkin lymphoma: the clinical perspective.Hepatitis C virus cryoglobulinemia and non-hodgkin lymphomaAssessment of antisperm antibodies in a sample of Egyptian patients with hepatitis C virus infection.Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytesShear wave elastography (SWE) of the spleen in patients with hepatitis B and C but without significant liver fibrosis.Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma.New use of an old drug: chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial).Hepatitis C virus infection and its rheumatologic implications.Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recipientsA retrospective analysis of treatment outcomes in patients with hepatitis C related systemic vasculitis receiving intravenous methylprednisolone and cyclophosphamide.Hepatitis B and hepatitis C viruses: a review of viral genomes, viral induced host immune responses, genotypic distributions and worldwide epidemiology
P2860
Q33839099-57717293-E166-45AF-99EC-63CA11AC25A5Q34029385-E8354589-5EE7-46BE-9392-791943994AA4Q35814151-A248954B-0FDA-48A0-A693-ED07466F4121Q37961614-56438F25-9E34-4DF9-8165-F29F82EA119FQ38003148-6ECEC2A2-E9F2-49D8-B274-8B07B81873D2Q39089789-340FC2AE-FB5E-4650-9893-3D2D3005D506Q39639979-981488BA-4FE4-46EE-A892-7F5110597219Q40574000-7B9F234D-A534-48D3-B567-8399A6B25B2CQ40584442-B6C83845-3EA5-444F-90E4-C830156CFA3DQ40747582-4FF6E1B5-2C19-4391-8958-B7EAB8A0BB57Q41560603-1039D0EC-524C-48A3-825C-415B9DEA3C02Q42551541-88F9A0F8-C7B8-4B66-9C9B-CC61180ADBC6Q43000401-E8E5AEC1-195C-4376-8B86-1E2F17AD05B2Q56786720-69839315-5F1E-4C0D-9986-3C46C0BDFA44
P2860
Hepatitis C virus lymphotropism and peculiar immunological phenotype: Effects on natural history and antiviral therapy
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Hepatitis C virus lymphotropis ...... history and antiviral therapy
@ast
Hepatitis C virus lymphotropis ...... history and antiviral therapy
@en
Hepatitis C virus lymphotropis ...... history and antiviral therapy
@nl
type
label
Hepatitis C virus lymphotropis ...... history and antiviral therapy
@ast
Hepatitis C virus lymphotropis ...... history and antiviral therapy
@en
Hepatitis C virus lymphotropis ...... history and antiviral therapy
@nl
prefLabel
Hepatitis C virus lymphotropis ...... history and antiviral therapy
@ast
Hepatitis C virus lymphotropis ...... history and antiviral therapy
@en
Hepatitis C virus lymphotropis ...... history and antiviral therapy
@nl
P2860
P356
P1476
Hepatitis C virus lymphotropis ...... history and antiviral therapy
@en
P2093
Giovanni Tarantino
Paolo Conca
P2860
P304
P356
10.3748/WJG.15.2305
P407
P577
2009-05-21T00:00:00Z